losartan has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinderliter, AL; Meadowcroft, AM; Patterson, JH; Pieper, JA; Williamson, KM | 1 |
| Chen, B; Liu, YH; Zeng, QT | 1 |
| Dong, B; Dong, QL; Jiang, H; Li, SY; Liu, CX; Liu, XX; Liu, ZZ; Wang, N; Xu, H; Yang, YP; Zhang, XH; Zhang, YH; Zhu, L | 1 |
1 trial(s) available for losartan and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
The effects of fluvastatin, a CYP2C9 inhibitor, on losartan pharmacokinetics in healthy volunteers.
Topics: Adolescent; Adult; Antihypertensive Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme Inhibitors; Diastole; Dizziness; Drug Interactions; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gastrointestinal Diseases; Humans; Indoles; Losartan; Male; Metabolic Clearance Rate; Prospective Studies; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Systole | 1999 |
2 other study(ies) available for losartan and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
[Comparative study of effects of fluvastatin and losartan on left ventricular remodeling in rat myocardial infarction].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticholesteremic Agents; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Indoles; Losartan; Myocardial Infarction; Random Allocation; Rats; Ventricular Remodeling | 2005 |
Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits.
Topics: Animals; Atherosclerosis; Chemokine CCL2; Cholesterol; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation; Indoles; Inflammation; Losartan; Macrophages; p38 Mitogen-Activated Protein Kinases; Plaque, Atherosclerotic; Rabbits | 2011 |